Establishes certain caffeine safety warnings for covered establishments for items with high caffeine; establishes caffeine labeling requirements for food and dietary supplements containing certain amounts of caffeine per serving.
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.